Imaging AI firm Brainomix is highlighting clinical results regarding its 360 e-Lung technology at the American College of Chest Physicians' (ACCP) CHEST conference in Chicago.
A study conducted by researchers at the University of Chicago, Weill Cornell Medical Center in New York, and the University of Alabama at Birmingham showed that e-Lung could have supported an earlier diagnosis of progressive pulmonary fibrosis in 62% of patients and up to 21 months earlier, according to the firm. It also found that e-Lung identified disease progression on CT in 77% of patients who had been deemed clinically stable, Brainomix said.
e-Lung consists of thousands of CT scans from academic institutions, according to the firm. It was cleared by the U.S. Food and Drug Administration (FDA) in 2024.
![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
